NCT02801071View on ClinicalTrials.gov

L-Citrulline in Patients With Post-Polio Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 14, 2016

Primary Completion Date

August 15, 2017

Study Completion Date

October 5, 2018

Conditions
Post-Polio Syndrome
Interventions
DRUG

15g L-citrulline daily p.o.

DRUG

Placebo

Trial Locations (1)

4056

University of Basel, Children's Hospital, Basel

All Listed Sponsors
lead

Dirk Fischer

OTHER

NCT02801071 - L-Citrulline in Patients With Post-Polio Syndrome | Biotech Hunter | Biotech Hunter